Format

Send to

Choose Destination
Toxicol In Vitro. 2019 Jun 7;60:281-292. doi: 10.1016/j.tiv.2019.05.020. [Epub ahead of print]

Protein pathway analysis to study development-dependent effects of acute and repeated trimethyltin (TMT) treatments in 3D rat brain cell cultures.

Author information

1
Translational Biomarker Group, Department of Internal Medicine Specialties, University of Geneva, Geneva, Switzerland; Swiss Centre for Applied Human Toxicology (SCAHT), Switzerland.
2
Swiss Centre for Applied Human Toxicology (SCAHT), Switzerland; Analytical Sciences, School of Pharmaceutical Sciences, Universities of Geneva and Lausanne, Geneva, Switzerland.
3
Swiss Centre for Applied Human Toxicology (SCAHT), Switzerland; Neuroproteomics group, Department of Clinical Neurosciences, University of Geneva, Geneva, Switzerland.
4
Swiss Centre for Applied Human Toxicology (SCAHT), Switzerland; Department of Physiology, University of Lausanne, Lausanne, Switzerland.
5
Translational Biomarker Group, Department of Internal Medicine Specialties, University of Geneva, Geneva, Switzerland; Swiss Centre for Applied Human Toxicology (SCAHT), Switzerland. Electronic address: Jean-Charles.Sanchez@unige.ch.

Abstract

Trimethyltin is an organometallic compound, described to be neurotoxic and to trigger neuroinflammation and oxidative stress. Previous studies associated TMT with the perturbation of mitochondrial function, or neurotransmission. However, the mechanisms of toxicity may differ depending on the duration of exposure and on the stage of maturation of brain cells. This study aim at elucidating whether the toxicity pathways triggered by a known neurotoxicant (TMT) differs depending on cell maturation stage or duration of exposure. To this end omics profiling of immature and differentiated 3D rat brain cell cultures exposed for 24 h or 10 days (10-d) to 0.5 and 1 μM of TMT was performed to better understand the underlying mechanisms of TMT associated toxicity. Proteomics identified 55 and 17 proteins affected by acute TMT treatment in immature and differentiated cultures respectively, while 10-day treatment altered 96 proteins in immature cultures versus 353 in differentiated. The results suggest different sensitivity to TMT depending on treatment duration and cell maturation. In accordance with known TMT mechanisms oxidative stress and neuroinflammation was observed after 10-d treatment at both maturation stages, whereas the neuroinflammatory process was more prominent in differentiated cultures than in the immature, no development-dependent difference could be detected for oxidative stress or synaptic neurodegeneration. Pathway analysis revealed that both vesicular trafficking and the synaptic machinery were strongly affected by 10-d TMT treatment in both maturation stages, as was GABAergic and glutamatergic neurotransmission. This study shows that omics approaches combined with pathway analysis constitutes an improved tool-set in elucidating toxicity mechanisms.

PMID:
31176792
DOI:
10.1016/j.tiv.2019.05.020

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center